Design of Phase III, Randomized, Placebo-Controlled Trials of BI 1015550 in Patients with Progressive Fibrosing Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis (FIBRONEER-ILD / -IPF) - Kreuter, M; Maher, T; Azuma, A; Cottin, V; Assassi, S; Hoffmann-Vold, A; Martinez, F; Oldham, J; Valenzuela, C; Wijsenbeek, M; Liu, Y; Wachtlin, D; Stowasser, S; Zoz, D; Richeldi, L (Pneumologie, 2023)